Holen Sie sich die Stockscreener-App
80.12
0.53%
-0.43
Vorhandelsmarkt:
80.12
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$80.55
Offen:
$80.61
24-Stunden-Volumen:
1.07M
Relative Volume:
0.52
Marktkapitalisierung:
$39.35B
Einnahmen:
$10.19B
Nettoeinkommen (Verlust:
$1.05B
KGV:
38.07
EPS:
2.1044
Netto-Cashflow:
$1.38B
1W Leistung:
+1.39%
1M Leistung:
+4.58%
6M Leistung:
-6.13%
1J Leistung:
-6.16%
1-Tages-Spanne:
$79.89
$80.72
1-Wochen-Bereich:
$78.81
$80.75
52-Wochen-Spanne:
$71.55
$99.20
Alcon Inc Stock (ALC) Company Profile
Vergleichen Sie ALC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
80.12 | 39.57B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
ISRG
Intuitive Surgical Inc
|
577.34 | 205.55B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
195.67 | 56.05B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
RMD
Resmed Inc
|
244.60 | 36.01B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
43.63 | 33.20B | 0 | 0 | 0 | 0.00 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-11 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-08-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-05-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Bestätigt | BTIG Research | Buy |
| 2025-03-28 | Bestätigt | Needham | Buy |
| 2025-03-25 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-01-24 | Bestätigt | Needham | Buy |
| 2025-01-10 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Bestätigt | Needham | Buy |
| 2024-11-12 | Bestätigt | Needham | Buy |
| 2024-10-10 | Hochstufung | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Eingeleitet | Goldman | Buy |
| 2024-03-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Eingeleitet | Bernstein | Outperform |
| 2023-12-18 | Herabstufung | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Hochstufung | Societe Generale | Sell → Hold |
| 2022-12-22 | Eingeleitet | Mizuho | Buy |
| 2022-11-17 | Herabstufung | Societe Generale | Hold → Sell |
| 2022-08-11 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-05-12 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-11 | Eingeleitet | BofA Securities | Buy |
| 2022-01-18 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Eingeleitet | Oppenheimer | Perform |
| 2021-07-14 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-06 | Hochstufung | Citigroup | Sell → Neutral |
| 2021-03-22 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-11-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-07-06 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-07-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-04-08 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Argus | Hold → Buy |
| 2020-03-24 | Hochstufung | Societe Generale | Sell → Hold |
| 2020-03-13 | Hochstufung | UBS | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-26 | Hochstufung | Berenberg | Hold → Buy |
| 2020-01-08 | Eingeleitet | Argus | Hold |
| 2019-10-29 | Eingeleitet | Stephens | Equal-Weight |
| 2019-08-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-06-24 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-06-14 | Eingeleitet | BTIG Research | Neutral |
| 2019-05-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-05-02 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Alcon Inc Aktie (ALC) Neueste Nachrichten
Can Alcon Inc. Ordinary Shares stock attract analyst upgradesDay Trading Setups & Budget Friendly Portfolio - Bollywood Helpline
Alcon (SWX:ALC): Evaluating Valuation After a Tentative Share Price Rebound - Yahoo Finance
Broadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon - marketscreener.com
Broadwood Partners denounces STAAR Surgical's delay of shareholder vote on Alcon deal - marketscreener.com
Broadwood Partners: Denounces STAAR Surgical's Delay Of Shareholder Vote On Alcon Deal - TradingView — Track All Markets
Is Alcon Inc. stock a safe haven assetJuly 2025 Movers & Technical Buy Zone Confirmations - ulpravda.ru
Can Alcon Inc. stock deliver consistent earnings growth2025 Major Catalysts & Verified Momentum Watchlists - Улправда
Is Alcon Inc. stock a buy on dipsJuly 2025 Final Week & Growth Focused Stock Pick Reports - Улправда
Why analysts remain bullish on Alcon Inc. stock2025 Big Picture & Capital Protection Trade Alerts - ulpravda.ru
Published on: 2025-12-20 10:10:42 - ulpravda.ru
Why Alcon Inc. stock could rally in 2025CPI Data & AI Powered Market Trend Analysis - ulpravda.ru
Exclusive: STAAR merger with Alcon still fails to gain traction, only 30% vote for - Investing.com UK
Alcon (ALC) Faces Opposition in STAAR Surgical Acquisition - GuruFocus
Will Alcon Inc. (2U3) stock see valuation expansionBull Run & Weekly Return Optimization Plans - ulpravda.ru
STAAR Surgical (STAA) Rises Amid Adjourned Shareholder Vote on A - GuruFocus
Big STAAR shareholder fights yet another delay on sale to Alcon - Stock Titan
Alcon (ALC) Postpones Special Meeting to January 2026 - GuruFocus
Alcon Exercises Right to Require STAAR Surgical to Delay Stockholder Meeting - marketscreener.com
Alcon Exercises Right To Require STAAR Surgical To Adjourn Its Special Meeting Of Stockholders - TradingView — Track All Markets
Eye implant maker delays shareholder vote on merger with Alcon - Stock Titan
Alcon exercises right to require Staar Surgical to adjourn its special meeting of stockholders, now will be held January 6 - marketscreener.com
Can Alcon Inc. Ordinary Shares stock surprise with quarterly resultsEarnings Risk Report & Long-Term Safe Investment Plans - DonanımHaber
What Wall Street predicts for Alcon Inc. stock pricePortfolio Return Report & Weekly Sector Rotation Insights - DonanımHaber
Is Alcon Inc. stock trading at a premium valuationPortfolio Risk Report & Free Community Consensus Stock Picks - DonanımHaber
Will Alcon Inc. stock deliver long term returnsPrice Action & Safe Entry Point Alerts - DonanımHaber
Aug Technicals: Does Alcon Inc. stock trade at a discount to peersPortfolio Gains Report & Low Risk High Win Rate Picks - DonanımHaber
How Alcon Inc. (ALC) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Lensar: Timing And Arbitrage Considerations In Alcon's Acquisition Bid (NASDAQ:LNSR) - Seeking Alpha
Alcon Inc. (NYSE:ALC) Q2 2025 Earnings Call Transcript - MSN
Defender Capital to vote against STAAR Surgical sale to Alcon By Investing.com - Investing.com Nigeria
Defender Capital to vote against STAAR Surgical sale to Alcon - Investing.com
Broadwood (NASDAQ: STAA) opposes Alcon buyout and plans STAAR board shake-up - Stock Titan
Defender Capital reiterates intention to vote against Staar Surgical's proposed sale to Alcon Inc. - marketscreener.com
Alcon (ALC) Acquisition of STAAR Surgical Faces Strong Oppositio - GuruFocus
STAAR urges stockholders to vote for Alcon merger amid proxy battle - Investing.com Nigeria
Broadwood urges shareholders to reject Alcon’s bid for STAAR By Investing.com - Investing.com Nigeria
Broadwood urges shareholders to reject Alcon’s bid for STAAR - Investing.com
Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails - marketscreener.com
Big STAAR investor fights Alcon buyout, says shares should hit $50 - Stock Titan
STAAR urges stockholders to vote for Alcon merger amid proxy battle By Investing.com - Investing.com South Africa
Alcon (ALC) Merger Proposal Faces Crucial Vote by STAAR Sharehol - GuruFocus
STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value - marketscreener.com
STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value | ALC Stock News - Stock Titan
Bernstein Bullish on Alcon's FY26 Earnings Growth Momentum; Outperform Maintained - marketscreener.com
STAAR Surgical’s Long-Term Shareholder Says Proposed Deal With Alcon Undervalues The Company - MSN
Proxy firms raise concerns over STAAR Surgical’s proposed sale to Alcon - Investing.com India
STAAR Surgical (NASDAQ: STAA) faces proxy fight over Alcon merger bid - Stock Titan
STAAR Surgical falls as proxy adviser recommends against revised Alcon deal (update) - MSN
Yunqi Capital opposes Alcon deal for STAAR Surgical (NASDAQ: STAA) at $30.75 - Stock Titan
STAAR Surgical stock jumps 10% after Alcon sweetens buyout offer — investor says deal is 'worth substantially more' - MSN
Yunqi Capital to vote against revised Alcon-STAAR merger offer By Investing.com - Investing.com South Africa
Finanzdaten der Alcon Inc-Aktie (ALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.84%
3.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):